A1E0F
Asimadoline
| Created: | 2025-11-08 |
| Last modified: | 2026-07-08 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 61 |
| Chiral Atom Count | 2 |
| Bond Count | 64 |
| Aromatic Bond Count | 18 |
Chemical Component Summary | |
|---|---|
| Name | Asimadoline |
| Synonyms | ~{N}-methyl-~{N}-[(1~{S})-2-[(3~{S})-3-oxidanylpyrrolidin-1-yl]-1-phenyl-ethyl]-2,2-diphenyl-ethanamide |
| Systematic Name (OpenEye OEToolkits) | ~{N}-methyl-~{N}-[(1~{S})-2-[(3~{S})-3-oxidanylpyrrolidin-1-yl]-1-phenyl-ethyl]-2,2-diphenyl-ethanamide |
| Formula | C27 H30 N2 O2 |
| Molecular Weight | 414.539 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | CN([CH](CN1CC[CH](O)C1)c2ccccc2)C(=O)C(c3ccccc3)c4ccccc4 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CN(C(CN1CCC(C1)O)c2ccccc2)C(=O)C(c3ccccc3)c4ccccc4 |
| Canonical SMILES | CACTVS | 3.385 | CN([C@H](CN1CC[C@H](O)C1)c2ccccc2)C(=O)C(c3ccccc3)c4ccccc4 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CN([C@H](CN1CC[C@@H](C1)O)c2ccccc2)C(=O)C(c3ccccc3)c4ccccc4 |
| InChI | InChI | 1.06 | InChI=1S/C27H30N2O2/c1-28(25(21-11-5-2-6-12-21)20-29-18-17-24(30)19-29)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26,30H,17-20H2,1H3/t24-,25+/m0/s1 |
| InChIKey | InChI | 1.06 | JHLHNYVMZCADTC-LOSJGSFVSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB05104 |
|---|---|
| Name | Asimadoline |
| Groups | investigational |
| Description | Asimadoline is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and has the potential for treating other gastrointestinal diseases. |
| Synonyms | Asimadoline |
| Indication | Investigated for use/treatment in irritable bowel syndrome (IBS). |
| Categories |
|
| CAS number | 153205-46-0 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Kappa-type opioid receptor | MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLE... | unknown | agonist |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682














